Gold prices traded lower in Asia on Friday morning amid hopes for COVID-19 vaccines from the U.S. and U.K. bolstered investor appetite. Sentiment was further boosted with the European Central Bank (ECB) signaling that it may leave interest rates and stimulus unchanged in the near future.
Gold futures slipped by 0.12% to $1,798.15 per ounce at 10:34 PM ET (3:34 AM GMT), falling slightly below the $1,800 mark.
European Central Bank President Christine Lagarde said during the ECB Governing Council meeting on Thursday that the central bank saw the current fiscal stimulus in Europe to remain necessary in the near future.
Meanwhile, U.S. biotech firm Moderna reported positive results earlier this week from early stage trials for its COVID-19 vaccine, which developed neutralizing antibodies in the bloodstream of all participants.
In the U.K., scientists have also developed a potential breakthrough for a COVID-19 vaccine that is being developed by researchers at Oxford University. The preliminary tests involved 5,000 volunteers and is currently underway in Brazil. Meanwhile, pharmaceutical company AstraZeneca has also agreed to have the vaccine mass-produced.
The Dollar fell to two-year lows on Friday, heading to its lowest decline in 10 years as concerns mounted over the economic recovery of the U.S. amid a second resurgence of the COVID-19 pandemic. The Dollar index plunged to 92.777, on course ...
Oil traded higher on Friday, further reclaiming lost ground from three-week lows in the previous session as the COVID-19 situation continued to dent the global economy as well as oil consumption. Brent crude gained 0.3%, trading at $43.08 ...
The dollar was briefly lifted on Thursday after the U.S. Federal Reserve offered no concrete clues about its next course of action, while investors hoped for an easy policy as the coronavirus resurgence stalled economic recovery. The dollar ...
The second quarter had seen Australian consumer prices dropping by a record. This could be attributed to the coronavirus crisis dragging child care cost and petroleum prices, inflicting a serious damage to years of growth toward higher inflation. Last ...
Britain on Wednesday signed a supply deal for up to 60 million doses of a possible COVID-19 vaccine that is being developed by pharmaceutical companies GlaxoSmithKline (GSK) and Sanofi. The financial details of the agreement were not disclosed. However, ...